LEP and breast neoplasm: High leptin levels have been also correlated with lower chemosensitivity, and a common nexus between leptin and several mechanisms that come usually activated in breast tumors—such as VEGF and other pro-angiogenic pathways or estrogen/progesteron receptor signaling—have also been identified [46,47,48,49].